NOMO1 inhibitors represent a class of chemical compounds that specifically target and inhibit the activity of the Nodal Modulator 1 (NOMO1) protein. NOMO1 is involved in the regulation of signaling pathways related to developmental processes, particularly in the context of the Nodal signaling pathway, which plays a key role in early embryogenesis and cellular differentiation. Inhibition of NOMO1 affects its ability to modulate these processes, disrupting the fine-tuning of molecular interactions within these pathways. Structurally, NOMO1 inhibitors typically exhibit a range of chemical functionalities, including aromatic rings, amide linkages, and heterocyclic scaffolds, allowing them to interact with key residues within the active site of NOMO1. These molecular interactions are essential for the inhibitors' binding affinity and specificity, often mediated by hydrogen bonding, hydrophobic interactions, and van der Waals forces.
From a mechanistic perspective, NOMO1 inhibitors generally act by competitively binding to NOMO1, preventing its interaction with other proteins or molecular targets in the signaling pathway. This interference can lead to the downregulation or modulation of various downstream effects, influencing gene expression and cellular dynamics. The structural diversity of NOMO1 inhibitors allows for variation in their potency and selectivity, with some compounds exhibiting highly selective inhibition while others may have broader interactions with related proteins. The development of NOMO1 inhibitors has led to a deeper understanding of the role of NOMO1 in cellular and developmental processes, providing insights into the intricacies of protein regulation within critical signaling networks. As research in this area progresses, further characterization of these inhibitors continues to shed light on their molecular mechanisms and biochemical properties.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
SB-431542 is an inhibitor of the TGF-β superfamily type I activin receptor-like kinases (ALKs), potentially impacting Nodal signaling and indirectly affecting NOMO1. | ||||||
LY 364947 | 396129-53-6 | sc-203122 sc-203122A | 5 mg 10 mg | $105.00 $153.00 | 4 | |
LY364947 is a potent inhibitor of TGF-β type I receptor ALK5, which can indirectly influence NOMO1 by modulating Nodal signaling. | ||||||
A 83-01 | 909910-43-6 | sc-203791 sc-203791A | 10 mg 50 mg | $198.00 $650.00 | 16 | |
A-83-01 inhibits ALK5, ALK4, and ALK7, which are involved in TGF-β and Nodal signaling, potentially affecting NOMO1 function. | ||||||
LY2157299 | 700874-72-2 | sc-391123 sc-391123A | 5 mg 10 mg | $209.00 $352.00 | 3 | |
LY2157299 is a selective inhibitor of TGF-β receptor I (ALK5), potentially influencing Nodal signaling pathways related to NOMO1. | ||||||
EW-7197 | 1352608-82-2 | sc-507465 | 5 mg | $345.00 | ||
EW-7197 is an inhibitor of ALK4, ALK5, and ALK7, impacting TGF-β and Nodal signaling, and may indirectly affect NOMO1. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $94.00 $348.00 | 69 | |
Dorsomorphin inhibits ALK2, ALK3, and ALK6, and can indirectly influence NOMO1 through modulation of BMP signaling, which intersects with Nodal pathways. | ||||||
4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | 1062368-24-4 | sc-476297 | 5 mg | $240.00 | ||
LDN-193189 is a selective ALK2 and ALK3 inhibitor, potentially affecting pathways that intersect with Nodal signaling and NOMO1. | ||||||
DMH-1 | 1206711-16-1 | sc-361171 sc-361171B sc-361171A sc-361171C | 10 mg 25 mg 50 mg 100 mg | $209.00 $312.00 $620.00 $1026.00 | 2 | |
DMH1 is a selective inhibitor of ALK2, impacting BMP signaling and potentially affecting Nodal signaling pathways related to NOMO1. | ||||||
ALK5 Inhibitor II | 446859-33-2 | sc-221234 sc-221234A sc-221234B sc-221234C sc-221234D sc-221234E sc-221234F | 1 mg 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $75.00 $150.00 $215.00 $650.00 $1224.00 $4296.00 $7818.00 | 8 | |
RepSox inhibits ALK5, impacting TGF-β signaling and potentially influencing Nodal signaling pathways involving NOMO1. | ||||||
SB-505124 | 694433-59-5 | sc-362794 sc-362794A | 10 mg 50 mg | $321.00 $1350.00 | 2 | |
SB-505124 inhibits ALK4, ALK5, and ALK7, affecting TGF-β and Nodal signaling pathways, potentially impacting NOMO1. | ||||||